Nevro Corp. (NYSE:NVRO)‘s stock had its “buy” rating reaffirmed by analysts at B. Riley in a report issued on Friday.

A number of other equities analysts have also recently commented on NVRO. Bank of America Corp. assumed coverage on shares of Nevro Corp. in a report on Monday, August 8th. They issued a “buy” rating on the stock. Wells Fargo & Co. assumed coverage on shares of Nevro Corp. in a report on Tuesday, July 12th. They issued an “outperform” rating on the stock. Piper Jaffray Cos. assumed coverage on shares of Nevro Corp. in a report on Friday, July 22nd. They issued an “overweight” rating on the stock. Finally, William Blair reaffirmed an “outperform” rating on shares of Nevro Corp. in a report on Monday, July 18th. Two equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $76.75.

Nevro Corp. (NYSE:NVRO) traded down 0.49% during trading on Friday, reaching $95.48. 114,847 shares of the company’s stock were exchanged. Nevro Corp. has a 52 week low of $36.51 and a 52 week high of $100.83. The firm’s market capitalization is $2.72 billion. The stock has a 50-day moving average price of $93.56 and a 200 day moving average price of $74.38.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/nevro-corp-nvro-receives-buy-rating-from-b-riley.html

Several large investors have recently modified their holdings of NVRO. Rhenman & Partners Asset Management AB bought a new stake in shares of Nevro Corp. during the first quarter valued at approximately $1,125,000. IFP Advisors Inc raised its stake in shares of Nevro Corp. by 16.5% in the first quarter. IFP Advisors Inc now owns 3,215 shares of the company’s stock valued at $181,000 after buying an additional 455 shares during the last quarter. Teachers Advisors Inc. raised its stake in shares of Nevro Corp. by 19.7% in the first quarter. Teachers Advisors Inc. now owns 28,771 shares of the company’s stock valued at $1,619,000 after buying an additional 4,739 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Nevro Corp. by 6.7% in the first quarter. Franklin Resources Inc. now owns 1,457,000 shares of the company’s stock valued at $81,970,000 after buying an additional 91,374 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Nevro Corp. by 1.4% in the first quarter. JPMorgan Chase & Co. now owns 852,758 shares of the company’s stock valued at $47,976,000 after buying an additional 11,695 shares during the last quarter.

About Nevro Corp.

Nevro Corp. is a medical device company. The Company has developed and commercialized a neuromodulation platform for the treatment of chronic pain. The Company’s Senza system is a spinal cord stimulation (SCS) system that delivers its HF10 therapy. HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain.

5 Day Chart for NYSE:NVRO

Receive News & Ratings for Nevro Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nevro Corp. and related companies with MarketBeat.com's FREE daily email newsletter.